"Dysbiosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Changes in quantitative and qualitative composition of MICROBIOTA. The changes may lead to altered host microbial interaction or homeostatic imbalance that can contribute to a disease state often with inflammation.
| Descriptor ID |
D064806
|
| MeSH Number(s) |
C23.550.308
|
| Concept/Terms |
Dysbiosis- Dysbiosis
- Dysbioses
- Disbiosis
- Disbioses
- Dys-symbiosis
- Dys symbiosis
- Dys-symbioses
Dysbacteriosis- Dysbacteriosis
- Dysbacterioses
- Disbacteriosis
- Disbacterioses
|
Below are MeSH descriptors whose meaning is more general than "Dysbiosis".
Below are MeSH descriptors whose meaning is more specific than "Dysbiosis".
This graph shows the total number of publications written about "Dysbiosis" by people in this website by year, and whether "Dysbiosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 2 | 2 |
| 2015 | 6 | 1 | 7 |
| 2016 | 4 | 3 | 7 |
| 2017 | 3 | 2 | 5 |
| 2018 | 7 | 2 | 9 |
| 2019 | 5 | 2 | 7 |
| 2020 | 5 | 7 | 12 |
| 2021 | 3 | 10 | 13 |
| 2022 | 1 | 8 | 9 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 5 | 6 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dysbiosis" by people in Profiles.
-
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy. Blood. 2025 Feb 20; 145(8):823-839.
-
Bacteroides ovatus alleviates dysbiotic microbiota-induced graft-versus-host disease. Cell Host Microbe. 2024 Sep 11; 32(9):1621-1636.e6.
-
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3?Tg-AD mice. Gut Microbes. 2024 Jan-Dec; 16(1):2389319.
-
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response. Clin Infect Dis. 2024 Jun 14; 78(6):1462-1472.
-
Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer. Front Biosci (Landmark Ed). 2024 Apr 18; 29(4):152.
-
Immunopathogenesis of Primary Biliary Cholangitis, Primary Sclerosing Cholangitis and Autoimmune Hepatitis: Themes and Concepts. Gastroenterology. 2024 06; 166(6):995-1019.
-
The pan-microbiome profiling system Taxa4Meta identifies clinical dysbiotic features and classifies diarrheal disease. J Clin Invest. 2024 Jan 16; 134(2).
-
Precision modulation of dysbiotic adult microbiomes with a human-milk-derived synbiotic reshapes gut microbial composition and metabolites. Cell Host Microbe. 2023 09 13; 31(9):1523-1538.e10.
-
MAdCAM-1: a newly identified microbial 'gut check' for T cells. Trends Immunol. 2023 08; 44(8):568-570.
-
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy. Nat Rev Clin Oncol. 2023 09; 20(9):583-603.